Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Trelagliptin Succinate Tablets

Approval Number

国药准字H20223113

Company四川科伦药业股份有限公司

Registration Date

March 8, 2022

Drug Information

Generic Name

琥珀酸曲格列汀片

Dosage Form

片剂

Strength

100mg（按C18H20FN5O2计）

Drug Type

化学药品

Registration Date

March 8, 2022

Company Information

Applicant Company

Company Name四川科伦药业股份有限公司

Company Address

成都市新都卫星城工业开发区南二路

Manufacturing Company

Company Name四川科伦药业股份有限公司

Company Address

资阳经济技术开发区安岳工业园（安岳县石桥铺镇）

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

琥珀酸曲格列汀片 - NMPA 批准文号 | MedPath